-
Foundational Models for Pathology and Endoscopy Images: Application for Gastric Inflammation
Authors:
Hamideh Kerdegari,
Kyle Higgins,
Dennis Veselkov,
Ivan Laponogov,
Inese Polaka,
Miguel Coimbra,
Junior Andrea Pescino,
Marcis Leja,
Mario Dinis-Ribeiro,
Tania Fleitas Kanonnikoff,
Kirill Veselkov
Abstract:
The integration of artificial intelligence (AI) in medical diagnostics represents a significant advancement in managing upper gastrointestinal (GI) cancer, a major cause of global cancer mortality. Specifically for gastric cancer (GC), chronic inflammation causes changes in the mucosa such as atrophy, intestinal metaplasia (IM), dysplasia and ultimately cancer. Early detection through endoscopic r…
▽ More
The integration of artificial intelligence (AI) in medical diagnostics represents a significant advancement in managing upper gastrointestinal (GI) cancer, a major cause of global cancer mortality. Specifically for gastric cancer (GC), chronic inflammation causes changes in the mucosa such as atrophy, intestinal metaplasia (IM), dysplasia and ultimately cancer. Early detection through endoscopic regular surveillance is essential for better outcomes. Foundation models (FM), which are machine or deep learning models trained on diverse data and applicable to broad use cases, offer a promising solution to enhance the accuracy of endoscopy and its subsequent pathology image analysis. This review explores the recent advancements, applications, and challenges associated with FM in endoscopy and pathology imaging. We started by elucidating the core principles and architectures underlying these models, including their training methodologies and the pivotal role of large-scale data in develo** their predictive capabilities. Moreover, this work discusses emerging trends and future research directions, emphasizing the integration of multimodal data, the development of more robust and equitable models, and the potential for real-time diagnostic support. This review aims to provide a roadmap for researchers and practitioners in navigating the complexities of incorporating FM into clinical practice for prevention/management of GC cases, thereby improving patient outcomes.
△ Less
Submitted 26 June, 2024;
originally announced June 2024.
-
Graph Attentional Autoencoder for Anticancer Hyperfood Prediction
Authors:
Guadalupe Gonzalez,
Shunwang Gong,
Ivan Laponogov,
Kirill Veselkov,
Michael Bronstein
Abstract:
Recent research efforts have shown the possibility to discover anticancer drug-like molecules in food from their effect on protein-protein interaction networks, opening a potential pathway to disease-beating diet design. We formulate this task as a graph classification problem on which graph neural networks (GNNs) have achieved state-of-the-art results. However, GNNs are difficult to train on spar…
▽ More
Recent research efforts have shown the possibility to discover anticancer drug-like molecules in food from their effect on protein-protein interaction networks, opening a potential pathway to disease-beating diet design. We formulate this task as a graph classification problem on which graph neural networks (GNNs) have achieved state-of-the-art results. However, GNNs are difficult to train on sparse low-dimensional features according to our empirical evidence. Here, we present graph augmented features, integrating graph structural information and raw node attributes with varying ratios, to ease the training of networks. We further introduce a novel neural network architecture on graphs, the Graph Attentional Autoencoder (GAA) to predict food compounds with anticancer properties based on perturbed protein networks. We demonstrate that the method outperforms the baseline approach and state-of-the-art graph classification models in this task.
△ Less
Submitted 16 January, 2020;
originally announced January 2020.
-
Learning Interpretable Disease Self-Representations for Drug Repositioning
Authors:
Fabrizio Frasca,
Diego Galeano,
Guadalupe Gonzalez,
Ivan Laponogov,
Kirill Veselkov,
Alberto Paccanaro,
Michael M. Bronstein
Abstract:
Drug repositioning is an attractive cost-efficient strategy for the development of treatments for human diseases. Here, we propose an interpretable model that learns disease self-representations for drug repositioning. Our self-representation model represents each disease as a linear combination of a few other diseases. We enforce proximity in the learnt representations in a way to preserve the ge…
▽ More
Drug repositioning is an attractive cost-efficient strategy for the development of treatments for human diseases. Here, we propose an interpretable model that learns disease self-representations for drug repositioning. Our self-representation model represents each disease as a linear combination of a few other diseases. We enforce proximity in the learnt representations in a way to preserve the geometric structure of the human phenome network - a domain-specific knowledge that naturally adds relational inductive bias to the disease self-representations. We prove that our method is globally optimal and show results outperforming state-of-the-art drug repositioning approaches. We further show that the disease self-representations are biologically interpretable.
△ Less
Submitted 20 October, 2019; v1 submitted 14 September, 2019;
originally announced September 2019.
